EVT Limited

EVT

AU000000EVT1

Leisure & Recreation

Market Closed - Australian S.E. Other stock markets 11:40:52 20/05/2024 am IST			5-day change	1st Jan Change
11.77 ^AUD	+0.77%		-1.26%	-3.76%

30/04	Evotec, Bayer to Focus on Precision Treatments for Cardiovascular Diseases	MT
24/04	Germany's Evotec Appoints Permanent CEO	MT

Amalgamated Holdings Ltd. Appoints David Stone as Company Secretary

February 23, 2012 at 06:57 am IST

Amalgamated Holdings Ltd. announced that David Stone has been appointed as a Company Secretary with effect from February 23, 2012. Greg Dean continues to be a Company Secretary of the company. The company also advises that, effective immediately, David Stone is responsible for communications with the company.

Latest news about EVT Limited

Evotec, Bayer to Focus on Precision Treatments for Cardiovascular Diseases	30/04	MT
Germany's Evotec Appoints Permanent CEO	24/04	MT
Evotec, Variant Bio Team Up to Develop Treatment for Fibrosis	18/04	MT
Evotec Names First Chief People Officer	17/04	MT
Jarden Adjusts EVT’s Price Target to AU$11.31 From AU$12.55, Keeps at Overweight	16/02	MT
Transcript : EVT Limited, H1 2024 Earnings Call, Feb 16, 2024	16/02
EVT's Net Profit Declines 72% in Fiscal H1 on Thredbo Impact	15/02	MT
EVT Limited Reports Earnings Results for the Half Year Ended December 31, 2023	15/02	CI
Economic Investment Trust Limited Announces Dividend	08/02	MT
Evotec's US Unit Expands Collaboration vs HIV with Advanced BioScience Laboratories	07/02	MT
Evotec Reiterates Trading Regulations Compliance Amid Former CEO’s Late Stock Trades Disclosure	22/01	MT
Evotec Receives $25 Million Under Neuroscience Collaboration with Bristol Myers Squibb	08/01	MT
Correction: Evotec, Owkin Team Up on AI-powered Research Across Oncology, Immunology, Inflammation	04/01	MT
Evotec, Owken Team Up on AI-powered Research Across Oncology, Immunology, Inflammation	04/01	MT
Evotec CEO to Step Down in 2026; Interim Successor Appointed	04/01	MT
Evotec Secures Grant for Teratogenicity Platform	19/12	MT
Economic Investment Trust Announced Final Results of its Substantial Issuer Bid	18/12	MT
Evotec Partners With German Institution for Expanded Autoimmune Diseases Patients Database; Shares Up	14/12	MT
Evotec, Glycotope Partner on Immune Cell Bispecifics Development Against Tumor	11/12	MT
Evotec Signs Strategic Oncology-focused Partnership With Dewpoint Therapeutics	07/11	MT
EVT Limited Provides Earnings Guidance for the Full Year 2023	20/23/20	CI
Transcript : EVT Limited - Shareholder/Analyst Call	20/23/20
Evotec Grants Three Partners Access to R&D Platform in Support of Biotech Innovation	27/23/27	MT
Evotec, Novo Nordisk Partner for Translational Drug Discovery Accelerator	26/23/26	MT
Transcript : EVT Limited, 2023 Earnings Call, Aug 28, 2023	28/23/28

Chart EVT Limited

Duration

Period

More charts

Company Profile

EVT Limited is an Australia-based company, which is engaged in the entertainment, ventures and travel business. The Company operates through five segments: Entertainment, Entertainment Germany, Hotels and Resorts, Thredbo Alpine Resort and Property and Other Investments. The Entertainment segment includes cinema exhibition operations in Australia and New Zealand, technology equipment supplies and servicing, and the State Theatre. The Entertainment Germany segment includes the cinema exhibition operations in Germany. The Hotels and Resorts segment includes the ownership, operation and management of hotels in Australia and New Zealand. The Thredbo Alpine Resort segment includes all the operations of the resort, including property development activities. The Property and Other Investments segment includes property rental, investment properties and investments designated at FVOCI.

Sector

Leisure & Recreation

Calendar

19/08/2024 - Q4 2024 Earnings Release (Projected)

Related indices

S&P/ASX 200

More about the company

Income Statement Evolution

More financial data

Ratings for EVT Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

11.68 AUD

Average target price

13.08 AUD

Spread / Average Target

+11.99%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Movie Theaters & Movie Products

	1st Jan change	Capi.
EVT LIMITED	-3.76%	126.71Cr
WANDA FILM HOLDING CO., LTD.	+5.30%	413.73Cr
CINEMARK HOLDINGS, INC.	+25.48%	211.96Cr
SHANGHAI FILM CO., LTD.	-.--%	166.39Cr
AMC ENTERTAINMENT HOLDINGS, INC.	-28.10%	161.96Cr
PVR INOX LIMITED	-20.10%	156.15Cr
HENGDIAN ENTERTAINMENT CO.,LTD	-13.16%	135.59Cr
KINEPOLIS GROUP NV	-12.64%	113.62Cr
PT NUSANTARA SEJAHTERA RAYA TBK	-21.48%	110.74Cr
SMI HOLDINGS GROUP LIMITED	-.--%	82Cr

Movie Theaters & Movie Products

EVT Limited

Equities

EVT

AU000000EVT1

Leisure & Recreation

Amalgamated Holdings Ltd. Appoints David Stone as Company Secretary

EPS Revisions